xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 14829 | SARS Spike (707-715) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVMPVSMAK | 9 | null | 707 | 715 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 19617 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 14829 | SARS Spike (707-715) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVMPVSMAK | 9 | null | 707 | 715 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 19613 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 14829 | SARS Spike (707-715) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVMPVSMAK | 9 | null | 707 | 715 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 19616 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 14829 | SARS Spike (707-715) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVMPVSMAK | 9 | null | 707 | 715 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 248 | 418 | Table 1 | Positive-High | true | 19.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 14829 | SARS Spike (707-715) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVMPVSMAK | 9 | null | 707 | 715 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 19612 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 14829 | SARS Spike (707-715) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVMPVSMAK | 9 | null | 707 | 715 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 19614 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 14829 | SARS Spike (707-715) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVMPVSMAK | 9 | null | 707 | 715 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 19615 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 33667 | SARS NP (362-370) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KTFPPTEPK | 9 | null | 362 | 370 | 10002316 | P59595.1 | null | Exact Epitope | Representative selection | MhcBinding | 19623 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 33667 | SARS NP (362-370) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KTFPPTEPK | 9 | null | 362 | 370 | 10002316 | P59595.1 | null | Exact Epitope | Representative selection | MhcBinding | 18451 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 33667 | SARS NP (362-370) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KTFPPTEPK | 9 | null | 362 | 370 | 10002316 | P59595.1 | null | Exact Epitope | Representative selection | MhcBinding | 250 | 418 | Table 1 | Positive-Intermediate | true | 70.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 33667 | SARS NP (362-370) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KTFPPTEPK | 9 | null | 362 | 370 | 10002316 | P59595.1 | null | Exact Epitope | Representative selection | MhcBinding | 19619 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 33667 | SARS NP (362-370) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KTFPPTEPK | 9 | null | 362 | 370 | 10002316 | P59595.1 | null | Exact Epitope | Representative selection | MhcBinding | 249 | 418 | Table 1 and Figure 3 | Positive-Intermediate | true | 186.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 33667 | SARS NP (362-370) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KTFPPTEPK | 9 | null | 362 | 370 | 10002316 | P59595.1 | null | Exact Epitope | Representative selection | MhcBinding | 19622 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 33667 | SARS NP (362-370) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KTFPPTEPK | 9 | null | 362 | 370 | 10002316 | P59595.1 | null | Exact Epitope | Representative selection | MhcBinding | 19618 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 33667 | SARS NP (362-370) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KTFPPTEPK | 9 | null | 362 | 370 | 10002316 | P59595.1 | null | Exact Epitope | Representative selection | MhcBinding | 19620 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 33667 | SARS NP (362-370) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KTFPPTEPK | 9 | null | 362 | 370 | 10002316 | P59595.1 | null | Exact Epitope | Representative selection | MhcBinding | 19621 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 4961 | SARS replicase (2577-2585) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATFSVPMEK | 9 | null | 2,577 | 2,585 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19628 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 4961 | SARS replicase (2577-2585) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATFSVPMEK | 9 | null | 2,577 | 2,585 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 252 | 418 | Table 1 | Positive-High | true | 28.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 4961 | SARS replicase (2577-2585) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATFSVPMEK | 9 | null | 2,577 | 2,585 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19624 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 4961 | SARS replicase (2577-2585) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATFSVPMEK | 9 | null | 2,577 | 2,585 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19626 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 4961 | SARS replicase (2577-2585) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATFSVPMEK | 9 | null | 2,577 | 2,585 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19629 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 4961 | SARS replicase (2577-2585) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATFSVPMEK | 9 | null | 2,577 | 2,585 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19625 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 4961 | SARS replicase (2577-2585) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATFSVPMEK | 9 | null | 2,577 | 2,585 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19627 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 4961 | SARS replicase (2577-2585) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATFSVPMEK | 9 | null | 2,577 | 2,585 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 251 | 418 | Table 1 and Figure 3 | Positive-Intermediate | true | 265.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 4961 | SARS replicase (2577-2585) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATFSVPMEK | 9 | null | 2,577 | 2,585 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 18458 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 34052 | SARS replicase (282-290) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KVIQPRVEK | 9 | null | 282 | 290 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 254 | 418 | Table 1 | Positive-Intermediate | true | 168.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 34052 | SARS replicase (282-290) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KVIQPRVEK | 9 | null | 282 | 290 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19634 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 34052 | SARS replicase (282-290) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KVIQPRVEK | 9 | null | 282 | 290 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 253 | 418 | Table 1 and Figure 3 | Positive-Low | true | 595.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 34052 | SARS replicase (282-290) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KVIQPRVEK | 9 | null | 282 | 290 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 18459 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 34052 | SARS replicase (282-290) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KVIQPRVEK | 9 | null | 282 | 290 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19630 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 34052 | SARS replicase (282-290) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KVIQPRVEK | 9 | null | 282 | 290 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19631 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 34052 | SARS replicase (282-290) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KVIQPRVEK | 9 | null | 282 | 290 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19632 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 34052 | SARS replicase (282-290) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KVIQPRVEK | 9 | null | 282 | 290 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19635 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 34052 | SARS replicase (282-290) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KVIQPRVEK | 9 | null | 282 | 290 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19633 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 54847 | SARS replicase (4882-4890) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RLYYDSMSY | 9 | null | 4,882 | 4,890 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19653 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 54847 | SARS replicase (4882-4890) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RLYYDSMSY | 9 | null | 4,882 | 4,890 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 256 | 418 | Table 1 | Positive-Intermediate | true | 237.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 54847 | SARS replicase (4882-4890) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RLYYDSMSY | 9 | null | 4,882 | 4,890 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19650 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 54847 | SARS replicase (4882-4890) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RLYYDSMSY | 9 | null | 4,882 | 4,890 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19655 | 278 | Figure 3 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 54847 | SARS replicase (4882-4890) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RLYYDSMSY | 9 | null | 4,882 | 4,890 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19654 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 54847 | SARS replicase (4882-4890) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RLYYDSMSY | 9 | null | 4,882 | 4,890 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 255 | 418 | Table 1 and Figure 3 | Positive-Intermediate | true | 52.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 54847 | SARS replicase (4882-4890) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RLYYDSMSY | 9 | null | 4,882 | 4,890 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 18460 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 54847 | SARS replicase (4882-4890) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RLYYDSMSY | 9 | null | 4,882 | 4,890 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19651 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 54847 | SARS replicase (4882-4890) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RLYYDSMSY | 9 | null | 4,882 | 4,890 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19652 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5447 | SARS replicase (3237-3245) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVLQSGFRK | 9 | null | 3,237 | 3,245 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19660 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5447 | SARS replicase (3237-3245) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVLQSGFRK | 9 | null | 3,237 | 3,245 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19659 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5447 | SARS replicase (3237-3245) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVLQSGFRK | 9 | null | 3,237 | 3,245 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 257 | 418 | Table 1 and Figure 3 | Positive-Intermediate | true | 259.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5447 | SARS replicase (3237-3245) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVLQSGFRK | 9 | null | 3,237 | 3,245 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19656 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5447 | SARS replicase (3237-3245) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVLQSGFRK | 9 | null | 3,237 | 3,245 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 258 | 418 | Table 1 | Positive-Intermediate | true | 80.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5447 | SARS replicase (3237-3245) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVLQSGFRK | 9 | null | 3,237 | 3,245 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19657 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5447 | SARS replicase (3237-3245) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVLQSGFRK | 9 | null | 3,237 | 3,245 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19658 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5447 | SARS replicase (3237-3245) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVLQSGFRK | 9 | null | 3,237 | 3,245 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 18505 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5447 | SARS replicase (3237-3245) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVLQSGFRK | 9 | null | 3,237 | 3,245 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 19661 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5297 | SARS replicase (4250-4258) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVDPAKAYK | 9 | null | 4,250 | 4,258 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20054 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5297 | SARS replicase (4250-4258) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVDPAKAYK | 9 | null | 4,250 | 4,258 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 261 | 418 | Table 1 and Figure 3 | Positive-Low | true | 1674.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5297 | SARS replicase (4250-4258) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVDPAKAYK | 9 | null | 4,250 | 4,258 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 18506 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5297 | SARS replicase (4250-4258) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVDPAKAYK | 9 | null | 4,250 | 4,258 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 263 | 418 | Table 1 | Positive-Intermediate | true | 124.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5297 | SARS replicase (4250-4258) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVDPAKAYK | 9 | null | 4,250 | 4,258 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20050 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5297 | SARS replicase (4250-4258) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVDPAKAYK | 9 | null | 4,250 | 4,258 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20052 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5297 | SARS replicase (4250-4258) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVDPAKAYK | 9 | null | 4,250 | 4,258 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20053 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5297 | SARS replicase (4250-4258) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVDPAKAYK | 9 | null | 4,250 | 4,258 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20055 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 5297 | SARS replicase (4250-4258) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVDPAKAYK | 9 | null | 4,250 | 4,258 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20051 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 74209 | SARS replicase (2361-2369) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YIFFASFYY | 9 | null | 2,361 | 2,369 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20059 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 74209 | SARS replicase (2361-2369) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YIFFASFYY | 9 | null | 2,361 | 2,369 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 265 | 418 | Table 1 | Positive-Intermediate | true | 347.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 74209 | SARS replicase (2361-2369) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YIFFASFYY | 9 | null | 2,361 | 2,369 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20060 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 74209 | SARS replicase (2361-2369) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YIFFASFYY | 9 | null | 2,361 | 2,369 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20056 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 74209 | SARS replicase (2361-2369) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YIFFASFYY | 9 | null | 2,361 | 2,369 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 264 | 418 | Table 1 and Figure 3 | Positive-Low | true | 1176.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 74209 | SARS replicase (2361-2369) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YIFFASFYY | 9 | null | 2,361 | 2,369 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20057 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 74209 | SARS replicase (2361-2369) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YIFFASFYY | 9 | null | 2,361 | 2,369 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20058 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 74209 | SARS replicase (2361-2369) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YIFFASFYY | 9 | null | 2,361 | 2,369 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 18507 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 74209 | SARS replicase (2361-2369) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YIFFASFYY | 9 | null | 2,361 | 2,369 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20061 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 30097 | SARS Spike (365-373) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KCYGVSATK | 9 | null | 365 | 373 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 20065 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 30097 | SARS Spike (365-373) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KCYGVSATK | 9 | null | 365 | 373 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 20064 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 30097 | SARS Spike (365-373) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KCYGVSATK | 9 | null | 365 | 373 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 266 | 418 | Table 1 and Figure 3 | Positive-Low | true | 2069.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 30097 | SARS Spike (365-373) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KCYGVSATK | 9 | null | 365 | 373 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 20062 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 30097 | SARS Spike (365-373) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KCYGVSATK | 9 | null | 365 | 373 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 20063 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 30097 | SARS Spike (365-373) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KCYGVSATK | 9 | null | 365 | 373 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 20066 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 30097 | SARS Spike (365-373) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KCYGVSATK | 9 | null | 365 | 373 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 267 | 418 | Table 1 | Positive-Low | true | 8376.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 30097 | SARS Spike (365-373) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KCYGVSATK | 9 | null | 365 | 373 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 18508 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 30097 | SARS Spike (365-373) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KCYGVSATK | 9 | null | 365 | 373 | 10002316 | P59594.1 | null | Exact Epitope | Representative selection | MhcBinding | 20067 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 51340 | SARS Ns6 (39-47) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLFKPLTKK | 9 | null | 39 | 47 | 10002316 | P59634.1 | null | Exact Epitope | Representative selection | MhcBinding | 268 | 418 | Table 1 and Figure 3 | Positive-Intermediate | true | 215.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 51340 | SARS Ns6 (39-47) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLFKPLTKK | 9 | null | 39 | 47 | 10002316 | P59634.1 | null | Exact Epitope | Representative selection | MhcBinding | 20069 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 51340 | SARS Ns6 (39-47) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLFKPLTKK | 9 | null | 39 | 47 | 10002316 | P59634.1 | null | Exact Epitope | Representative selection | MhcBinding | 20071 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 51340 | SARS Ns6 (39-47) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLFKPLTKK | 9 | null | 39 | 47 | 10002316 | P59634.1 | null | Exact Epitope | Representative selection | MhcBinding | 269 | 418 | Table 1 | Positive-Intermediate | true | 237.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 51340 | SARS Ns6 (39-47) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLFKPLTKK | 9 | null | 39 | 47 | 10002316 | P59634.1 | null | Exact Epitope | Representative selection | MhcBinding | 20068 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 51340 | SARS Ns6 (39-47) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLFKPLTKK | 9 | null | 39 | 47 | 10002316 | P59634.1 | null | Exact Epitope | Representative selection | MhcBinding | 20070 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 51340 | SARS Ns6 (39-47) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLFKPLTKK | 9 | null | 39 | 47 | 10002316 | P59634.1 | null | Exact Epitope | Representative selection | MhcBinding | 20072 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 51340 | SARS Ns6 (39-47) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLFKPLTKK | 9 | null | 39 | 47 | 10002316 | P59634.1 | null | Exact Epitope | Representative selection | MhcBinding | 18509 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 51340 | SARS Ns6 (39-47) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLFKPLTKK | 9 | null | 39 | 47 | 10002316 | P59634.1 | null | Exact Epitope | Representative selection | MhcBinding | 20073 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 31833 | SARS replicase (5432-5440) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KLFAAETLK | 9 | null | 5,432 | 5,440 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 270 | 418 | Table 1 and Figure 3 | Positive-Intermediate | true | 376.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 31833 | SARS replicase (5432-5440) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KLFAAETLK | 9 | null | 5,432 | 5,440 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20074 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 31833 | SARS replicase (5432-5440) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KLFAAETLK | 9 | null | 5,432 | 5,440 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 271 | 418 | Table 1 | Positive-Intermediate | true | 234.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 31833 | SARS replicase (5432-5440) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KLFAAETLK | 9 | null | 5,432 | 5,440 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20078 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 31833 | SARS replicase (5432-5440) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KLFAAETLK | 9 | null | 5,432 | 5,440 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 18510 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 31833 | SARS replicase (5432-5440) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KLFAAETLK | 9 | null | 5,432 | 5,440 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20077 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 31833 | SARS replicase (5432-5440) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KLFAAETLK | 9 | null | 5,432 | 5,440 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20075 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 31833 | SARS replicase (5432-5440) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KLFAAETLK | 9 | null | 5,432 | 5,440 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20079 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 31833 | SARS replicase (5432-5440) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KLFAAETLK | 9 | null | 5,432 | 5,440 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20076 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 56289 | SARS replicase (2140-2148) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RVFNNYMPY | 9 | null | 2,140 | 2,148 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20082 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 56289 | SARS replicase (2140-2148) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RVFNNYMPY | 9 | null | 2,140 | 2,148 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 20085 | 278 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
329.xml | 329 | 2024-08-19-07:00 | 15104671 | 2,004 | SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. | Tissue antigens | C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus | 56289 | SARS replicase (2140-2148) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RVFNNYMPY | 9 | null | 2,140 | 2,148 | 10002316 | P59641.2 | null | Exact Epitope | Representative selection | MhcBinding | 272 | 418 | Table 1 and Figure 3 | Positive-Intermediate | true | 358.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.